Application of caffeic acid in preventing and treating colorectal cancer and medicine containing caffeic acid

The invention provides application of caffeic acid in prevention and treatment of colorectal cancer and a medicine containing the caffeic acid. Comprising one or more of application in preparation of a colorectal cancer cell proliferation inhibitor, application in preparation of a colorectal cancer cell dryness maintenance inhibitor, application in preparation of a medicine for inhibiting or treating colorectal cancer tumor migration and application in preparation of a medicine for preventing relapse and/or treating colorectal cancer tumors. The application disclosed by the invention provides an effective prevention and treatment means for colorectal cancer; through combined application of epigenetic anti-cancer drugs and traditional chemotherapeutic drugs, multi-target treatment can be achieved, and the synergistic effect can be achieved to the maximum extent..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 28. Juli Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

GAO SHEGAN [VerfasserIn]
CHEN PAN [VerfasserIn]
ZHANG ZICHAO [VerfasserIn]
LANG YAOWU [VerfasserIn]
ZHAO QI [VerfasserIn]
QI YIJUN [VerfasserIn]
ZHANG DINGYU [VerfasserIn]
HAN HONGBO [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-07-28, Last update posted on www.tib.eu: 2023-11-28, Last updated: 2023-12-01

Patentnummer:

CN116492324

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018266452